The univariate analysis showed metastases in 3 or more organs, gefitinib/erlotinib use, and high SUVmax showed a trend of association with shorter PFS.
← all excerpts
Diagnostic and Predictive Values of <sup>18</sup>F-FDG PET/CT Metabolic Parameters in <i>EGFR</i>-Mutated Advanced Lung Adenocarcinoma.
1
—
—